Medicas

What Medicas does

Medicas is a consumer-facing telehealth platform operated by EGS Health Private Limited, an Indian private limited company registered in Srikakulam, Andhra Pradesh. The platform enables patients to consult doctors via video or chat, book appointments with specialists, schedule lab tests with home sample collection, and receive digital prescriptions and health records through iOS and Android apps and a web interface. It spans 35+ medical specialties including general practice, oncology, cardiology, pediatrics, and endocrinology, and serves consumers across 100+ Indian cities and six Caribbean nations (Barbados, Grenada, Trinidad and Tobago, Guyana, Dominica, Jamaica) with country-specific domains.

The product surface extends beyond core consultations into higher-value specialty programs: MC3 (Medicas Comprehensive Cancer Care) provides international tumor board reviews and second opinions through US board-certified oncologists; Genomic Health Insights and NutriDNA offer genetic screening across 60+ markers covering hereditary cancer, cardiovascular, pharmacogenomics, and personalized nutrition/fitness; and a structured Diabetes Management Program delivers virtual endocrinologist consultations plus lab testing. The underlying technology stack is a cloud-based, HIPAA-compliant telemedicine platform with encrypted health data storage, integrated appointment booking, e-prescription delivery, and a basic AI-powered chat support layer. Distribution is product-led growth via app stores and self-serve sign-up.

Medicas generates revenue through a mix of transaction fees (per-consultation starting at ₹200, specialist fees ranging up to ₹7,500+, lab test bookings, and one-time health packages), recurring annual subscriptions (Medicas 24/7 Doctor Subscription — Individual and Family tiers), and specialty service fees (cancer care, genomic screening). Customer segments include busy professionals, parents and families, seniors with mobility limitations, families in remote areas with limited healthcare infrastructure, and general consumers preferring home-based care. No funding rounds, revenue figures, or enterprise customer contracts are disclosed, and the company appears to be founder/owner-operated under the EGS Health umbrella.

Name

Medicas

Legal name

EGS-Health PVT LTD

Website

https://medicasapp.com

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

Medicas is an India- and Caribbean-based telehealth platform, operated by EGS Health Private Limited, that enables consumers to consult verified doctors via video/chat, book lab tests with home sample collection, and access specialty programs including oncology second opinions (MC3), genomic screening (NutriDNA), and chronic disease management.

Ownership category

akta.pro rank

Product category

Telemedicine Services

NAICS

Offices of Physicians (6211), Offices of Physicians (62111), Home Health Care Services (621610)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro industry

PRIMARYHLALAAAA

Primary Care & General Medicine Virtual Care

Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

SECONDARYHLALAJAA

24/7 On-Demand Urgent Care Virtual Visit Platforms

Healthcare & Life Sciences/Telehealth Platforms/Urgent Care & On-Demand Triage Telehealth Platforms

Keywords

• Online doctor consultation
• Telemedicine platform
• Lab test booking
• Cancer care coordination
• Genomic health screening

Headquarters

HQ city

Visakhapatnam

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Online Doctor Consultations: Revenue from video and chat consultations with doctors. Minimum consultation fee starts at ₹200 (excluding taxes). Specialists set their own fees displayed on platform.
2. Subscription Plans: Medicas 24/7 Doctor Subscription Plan available for Individual and Family coverage. Includes unlimited 24/7 GP consultations, annual health checkups, specialist consultations, discounts on lab tests, wellness webinars, and access to global specialists.
3. Lab Test Bookings: Platform facilitates booking of diagnostic tests through partner laboratories with home sample collection. Revenue derived from test bookings.
4. Health Packages: Preventive care and chronic condition monitoring packages available for purchase.
5. Cancer Care Services (MC3): Second opinions, international tumor board reviews, and coordinated oncology services with global specialists.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Medicas is a cloud-based telemedicine platform operated by EGS Health Private Limited that enables patients to book and conduct online video/chat consultations with verified doctors across 35+ specialties, schedule lab tests with home sample collection, purchase preventive health packages, and access specialty programs including comprehensive cancer care (MC3) and genomic health screening (NutriDNA). The service is delivered through iOS/Android mobile apps and a website across India (100+ cities) and six Caribbean nations.

Product overview

Medicas is a unified telehealth platform operated by EGS Health that offers online doctor consultations, appointment booking, lab test scheduling, and health management services. The core product is the Medicas App (available on iOS and Android) which serves as the primary interface for accessing all services. The platform integrates multiple service lines: the Medicas 24/7 Doctor Subscription Plan provides year-round healthcare access; MC3 (Medicas Comprehensive Cancer Care) delivers specialized oncology services including international second opinions; Genomic Health Insights and NutriDNA offer genetic-based wellness testing; Medicas Lab Tests and Health Packages provide diagnostic services through third-party laboratory partners; and the Diabetes Management Program delivers structured chronic disease management. Additional features include E-Prescriptions, Health Records storage, and an AI-powered chat assistant. The platform operates across India and Caribbean markets (Barbados, Grenada, Trinidad and Tobago, Guyana, Dominica, Jamaica).

Differentiator

Problem solved

Functional benefit

Brands

• MC3 (Medicas Comprehensive Cancer Care): Integrated cancer care program offering second opinions, diagnostics coordination, emotional support, and rehabilitation services through international oncology specialists.

Products and services

• Medicas App

Quantifiable outcome

• 60+ genetic markers analyzed with personalized report and free counselling
• +2 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Lybrate: Lybrate is an Indian doctor consultation and health content platform serving consumers seeking GP and specialist advice online; directly comparable on DTC telehealth, multi-specialty coverage, and India-targeted GTM.
• HealthTap: HealthTap is a US-based DTC virtual primary care and urgent care platform offering 24/7 video/chat consultations and subscription plans; directly comparable on consumer-facing 24/7 GP access, subscription tiers, and cross-specialty coverage.
• Practo: Practo is India's largest consumer telehealth and doctor-booking platform offering online consultations, appointment booking, and integrated health records; directly comparable because it serves the same busy-professional, family, and senior consumer segments via mobile-first video/chat consultations across Indian cities.
• MFine: MFine is an Indian on-demand telehealth platform delivering AI-assisted consultations, specialty care, and lab partnerships via mobile app; directly comparable in target customers (urban working professionals, families) and subscription/transaction revenue mix.

Broad incumbents

• Apollo Telehealth (Apollo 24/7): Apollo 24/7 is the digital arm of Apollo Hospitals offering online doctor consultations, lab tests, and home sample collection; comparable as a broad incumbent that combines a trusted hospital brand with the same consult-plus-diagnostics service mix as Medicas.
• TATA 1mg: TATA 1mg is a broad digital health incumbent combining e-pharmacy, lab test booking, teleconsultation, and health content for Indian consumers; overlaps with Medicas on lab test bookings, generic teleconsultation, and preventive health packages.
• Amwell: Amwell is a broad telehealth incumbent serving payers, employers, and health systems with on-demand urgent care and behavioral health visits; comparable as a broad incumbent whose urgent care and behavioral modules overlap with Medicas' specialist consultation suite.
• Teladoc Health: Teladoc Health is a global telehealth incumbent offering virtual primary care, mental health, and specialty services; relevant as a broad incumbent demonstrating how DTC virtual care scales and integrates specialty verticals like oncology - analogous to Medicas' MC3 program.

Emerging players

• PhableCare: PhableCare is an India-focused chronic disease management telehealth platform serving diabetes and related conditions; comparable to Medicas' Diabetes Management Program offering virtual endocrinologist consultations, dietary counseling, and structured lab testing.

Regional players

• Doctolib: Doctolib is a European doctor booking and telehealth platform with strong consumer brand and integrated health records; serves as a regional benchmark for how consumer telehealth marketplaces build defensible distribution and subscription/recurring booking revenue in their respective geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCA9FV0WN2vV8t_22MhKJjfA
• Facebookfacebook.com/MedicasTelehealth
• Instagraminstagram.com/medicastelehealth
• Xx.com/medicashealth

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Medicas